DK1696940T3 - Universelt anvendeligt virus-inaktiveret blodplasma fremstillet fra portioner af ikke-kaukasisk plasma - Google Patents

Universelt anvendeligt virus-inaktiveret blodplasma fremstillet fra portioner af ikke-kaukasisk plasma

Info

Publication number
DK1696940T3
DK1696940T3 DK04804944T DK04804944T DK1696940T3 DK 1696940 T3 DK1696940 T3 DK 1696940T3 DK 04804944 T DK04804944 T DK 04804944T DK 04804944 T DK04804944 T DK 04804944T DK 1696940 T3 DK1696940 T3 DK 1696940T3
Authority
DK
Denmark
Prior art keywords
blood
plasma
caucasian
portions
blood plasma
Prior art date
Application number
DK04804944T
Other languages
English (en)
Inventor
Andrea Heger
Juergen Roemisch
Tor-Einar Svae
Wolfgang Marguerre
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK1696940T3 publication Critical patent/DK1696940T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00—Compounds of titanium
    • C01G23/04—Oxides; Hydroxides
    • C01G23/047—Titanium dioxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
DK04804944T 2003-12-19 2004-12-20 Universelt anvendeligt virus-inaktiveret blodplasma fremstillet fra portioner af ikke-kaukasisk plasma DK1696940T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03029359 2003-12-19
PCT/EP2004/053608 WO2005058334A1 (en) 2003-12-19 2004-12-20 A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma

Publications (1)

Publication Number Publication Date
DK1696940T3 true DK1696940T3 (da) 2007-07-30

Family

ID=34684548

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04804944T DK1696940T3 (da) 2003-12-19 2004-12-20 Universelt anvendeligt virus-inaktiveret blodplasma fremstillet fra portioner af ikke-kaukasisk plasma

Country Status (23)

Country Link
US (2) US20070071829A1 (da)
EP (1) EP1696940B1 (da)
JP (1) JP2007514716A (da)
KR (1) KR101077976B1 (da)
CN (1) CN1893960B (da)
AT (1) ATE357242T1 (da)
AU (1) AU2004298790B2 (da)
BR (1) BRPI0417680A (da)
CA (1) CA2550060A1 (da)
CY (1) CY1106661T1 (da)
DE (1) DE602004005501T2 (da)
DK (1) DK1696940T3 (da)
ES (1) ES2281848T3 (da)
IL (1) IL175558A0 (da)
NO (1) NO20062360L (da)
PL (1) PL1696940T3 (da)
PT (1) PT1696940E (da)
RS (1) RS50508B (da)
RU (1) RU2362571C2 (da)
SI (1) SI1696940T1 (da)
UA (1) UA83528C2 (da)
WO (1) WO2005058334A1 (da)
ZA (1) ZA200604941B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
FR2963737B1 (fr) * 2010-08-16 2013-04-05 Etat Francais Ministere De La Defense Service De Sante Des Armees Procede de lyophilisation de plasma sanguin
EP3093035A1 (en) 2015-05-13 2016-11-16 Sanofi-Aventis Deutschland GmbH Injection device for delivery of a liquid medicament
CN107496453A (zh) * 2017-08-13 2017-12-22 发贵科技（贵州）有限公司 一种有病毒灭活功能的血浆抗凝剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664913A (en) * 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US5217627A (en) * 1990-11-06 1993-06-08 Pall Corporation System and method for processing biological fluid
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors
DE19729778A1 (de) * 1997-07-11 1999-01-21 Blutspendedienst Der Drk Lande Verfahren zur Herstellung von virusinaktivierten biologischen Flüssigkeiten
EP0896824A1 (en) * 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material

Also Published As

Publication number Publication date
NO20062360L (no) 2006-05-23
DE602004005501D1 (de) 2007-05-03
RS50508B (sr) 2010-03-02
CN1893960B (zh) 2012-10-31
CA2550060A1 (en) 2005-06-30
PL1696940T3 (pl) 2007-08-31
RU2006126055A (ru) 2008-01-27
US20110104298A1 (en) 2011-05-05
ES2281848T3 (es) 2007-10-01
JP2007514716A (ja) 2007-06-07
DE602004005501T2 (de) 2007-11-29
RU2362571C2 (ru) 2009-07-27
PT1696940E (pt) 2007-05-31
EP1696940B1 (en) 2007-03-21
US20070071829A1 (en) 2007-03-29
UA83528C2 (uk) 2008-07-25
WO2005058334A1 (en) 2005-06-30
ZA200604941B (en) 2007-11-28
ATE357242T1 (de) 2007-04-15
KR101077976B1 (ko) 2011-10-28
CY1106661T1 (el) 2012-05-23
AU2004298790B2 (en) 2010-04-08
SI1696940T1 (sl) 2007-08-31
EP1696940A1 (en) 2006-09-06
CN1893960A (zh) 2007-01-10
KR20060126662A (ko) 2006-12-08
AU2004298790A1 (en) 2005-06-30
BRPI0417680A (pt) 2007-03-20
IL175558A0 (en) 2006-09-05

Similar Documents

Publication Publication Date Title
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
EP1933852A4 (en) AMNION PREPARATIONS AND CLEANED COMPOSITIONS AND APPLICATION PROCEDURES
ECSP055725A (es) Formulaciones nutricionales que contienen sustancias simbióticas
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
EA200802213A1 (ru) Способы лечения заболеваний крови
DE602004022316D1 (de) Legierungszusammensetzungen und diese enthaltende vorrichtungen
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
LTC1608344I2 (lt) Per burną vartojamos kladribino kompozicijos
BR0317822A (pt) Composição fluoroquìmica
DK1866324T3 (da) Phosphoramidatderivater af nukleosidforbindelser til anvendelse i behandlingen af cancer
CR7901A (es) Pirazolilcarboxanilidas para la lucha contra los microorganismos indeseados
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
DK1753440T3 (da) Oral administrationsform indeholdende probiotiske bakterier
ATE468317T1 (de) Herstellung von 1,3-diphenylprop-2-en-1- onderivaten
AR047526A1 (es) Halogenoalquilcarboxamidas
DE60232880D1 (de) Gpe-analoga und peptidomimetika
IL178727A0 (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
DE60321594D1 (de) Synergistische zusammensetzungen
DE602004005501D1 (de) Universell einsetzbares virus-inaktiviertes blutplasma aus teilen von plasma, das nicht von weisshäutigen stammt
AR060155A1 (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas
DK1633373T3 (da) Farmaceutisk sammensætning indeholdende glucan hidrørende fra mikroalger
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
MX2021007646A (es) Inhibicion de la coagregacion especifica por arginina.
ATE394386T1 (de) 2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren